AU6418396A - Epimers of (22RS)-N-(1,1,1-trifluoro-2-phenylprop-2-yl)-3-ox-4-aza-5alp ha-androst-1-ene-17beta-carboxamide - Google Patents

Epimers of (22RS)-N-(1,1,1-trifluoro-2-phenylprop-2-yl)-3-ox-4-aza-5alp ha-androst-1-ene-17beta-carboxamide

Info

Publication number
AU6418396A
AU6418396A AU64183/96A AU6418396A AU6418396A AU 6418396 A AU6418396 A AU 6418396A AU 64183/96 A AU64183/96 A AU 64183/96A AU 6418396 A AU6418396 A AU 6418396A AU 6418396 A AU6418396 A AU 6418396A
Authority
AU
Australia
Prior art keywords
5alp
17beta
androst
phenylprop
epimers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64183/96A
Other languages
English (en)
Inventor
Enrico Di Salle
Marcella Nesi
Achille Panzeri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Publication of AU6418396A publication Critical patent/AU6418396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU64183/96A 1995-07-21 1996-06-28 Epimers of (22RS)-N-(1,1,1-trifluoro-2-phenylprop-2-yl)-3-ox-4-aza-5alp ha-androst-1-ene-17beta-carboxamide Abandoned AU6418396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI95A1587 1995-07-21
IT95MI001587A IT1275594B1 (it) 1995-07-21 1995-07-21 Epimeri del (22rs)-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-osso -4-aza-5alfa-androst-1-ene-17beta-carbossammide
PCT/EP1996/002830 WO1997004002A1 (en) 1995-07-21 1996-06-28 EPIMERS OF (22RS)-N-(1,1,1-TRIFLUORO-2-PHENYLPROP-2-YL)-3-OXO-4-AZA-5α-ANDROST-1-ENE-17β-CARBOXAMIDE

Publications (1)

Publication Number Publication Date
AU6418396A true AU6418396A (en) 1997-02-18

Family

ID=11372032

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64183/96A Abandoned AU6418396A (en) 1995-07-21 1996-06-28 Epimers of (22RS)-N-(1,1,1-trifluoro-2-phenylprop-2-yl)-3-ox-4-aza-5alp ha-androst-1-ene-17beta-carboxamide

Country Status (17)

Country Link
EP (1) EP0782582A1 (no)
JP (1) JPH10506411A (no)
KR (1) KR970706298A (no)
CN (1) CN1159195A (no)
AR (1) AR003967A1 (no)
AU (1) AU6418396A (no)
BR (1) BR9606527A (no)
CA (1) CA2199273A1 (no)
EA (1) EA199700045A1 (no)
HU (1) HUP9702465A3 (no)
IL (1) IL120343A0 (no)
IT (1) IT1275594B1 (no)
MX (1) MX9701948A (no)
NO (1) NO971196L (no)
PL (1) PL319351A1 (no)
WO (1) WO1997004002A1 (no)
ZA (1) ZA965678B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000013509A1 (en) * 1998-09-09 2000-03-16 Merck & Co., Inc. Method of determining and reducing the risk of bph-related urologic events
EP1146873B1 (en) * 1999-01-25 2005-03-16 Smithkline Beecham Corporation Anti-androgens and methods for treating disease
CN100355772C (zh) * 2005-12-28 2007-12-19 天津大学 具有5α-还原酶抑制活性的甾体化合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216284D0 (en) * 1992-07-31 1992-09-16 Erba Carlo Spa Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives

Also Published As

Publication number Publication date
ITMI951587A1 (it) 1997-01-21
NO971196D0 (no) 1997-03-14
CA2199273A1 (en) 1997-02-06
ITMI951587A0 (it) 1995-07-21
IL120343A0 (en) 1997-06-10
BR9606527A (pt) 1997-12-23
PL319351A1 (en) 1997-08-04
ZA965678B (en) 1997-01-24
HUP9702465A2 (hu) 1998-05-28
JPH10506411A (ja) 1998-06-23
MX9701948A (es) 1997-06-28
CN1159195A (zh) 1997-09-10
HUP9702465A3 (en) 1998-11-30
IT1275594B1 (it) 1997-08-06
EA199700045A1 (ru) 1997-12-30
EP0782582A1 (en) 1997-07-09
AR003967A1 (es) 1998-09-30
WO1997004002A1 (en) 1997-02-06
NO971196L (no) 1997-03-14
KR970706298A (ko) 1997-11-03

Similar Documents

Publication Publication Date Title
AU4786496A (en) New forms of paroxetin hydrochloride
AU4919496A (en) Potentiators of antibacterial agents
PL324992A1 (en) Novel derivatives of 2,3-dioxotetrahydoquinoxaline
AU4329396A (en) Use of 3,4-diphenylchromans
AU699020B2 (en) Liquid formulations of 1,2-benzisothiazolin-3-one
AU3284395A (en) Synthesis of 1,1,1,3,3,-pentafluoropropane
ZA969221B (en) Indolealkyl derivatives of benzodioxanmethylamine.
AU6944596A (en) Novel benzamide derivatives
AU6250496A (en) Eyedrop applicator
AU6123196A (en) N-aryl-1,2,4-triazolin-5-ones
AU4702496A (en) Oral compositions of h2-antagonists
AU4839196A (en) Polyazacycloalkane compounds
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU6180896A (en) Improved synthesis of 2,4,6,8,10,12-hexabenzyl-2,4,6,8,10,12-hexaazatetracyclo{5.5 .0.05,9.03,11}dodecane
AU4729396A (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
AU4712696A (en) The use of heterocyclic compounds
AU2497595A (en) New uses of difluoromethoxy-2,2,2-trifluoroethane
AU4361696A (en) New uses of indolo-{2,3b}-quinoxalines
AU4877196A (en) Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
AU5526196A (en) Compositions for the treatment of dandruff
AU1217797A (en) New compounds
AU7287596A (en) Strengthening agent
AU6418396A (en) Epimers of (22RS)-N-(1,1,1-trifluoro-2-phenylprop-2-yl)-3-ox-4-aza-5alp ha-androst-1-ene-17beta-carboxamide
AU1870295A (en) Novel derivatives of tetramethylcyclopropane
AU6657596A (en) Trindene compounds